Background Biohaven Pharmaceuticals is studying rimegepant, for the treatment of Trigeminal Neuraligia (TN). If you are 18 years or older and suffer from TN, you may qualify. This is a
In March 2021, the article “Microvascular Transposition Without Teflon: A Single Institution’s 17-Year Experience Treating Trigeminal Neuralgia” was published in the peer-reviewed journal Operative Neurosurgery. The senior author and surgeon of
